4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-18-000520
Chief Legal Officer sold 38,000 shares at an average $21.64 ($822,500)
- Chief Legal Officer acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Dylan-Hyde Tyler · Chief Legal Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-01-02 | Sale : show line 1 in the form | −30,000 | $20.55 | $616,500 | 70,204 | D |
| 2018-01-02 | Exercise or conversion : show line 2 in the form | +8,000 | $12.57 | $100,560 | 78,204 | D |
| 2018-01-02 | Sale : show line 3 in the form | −8,000 | $25.75 | $206,000 | 70,204 | D |
| Open-market sales · 38,000 sh · avg $21.64 · $822,500 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-01-02 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −6,490 | 37,773 | D |
| 2018-01-02 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −1,510 | 25,157 | D |
Loading xslF345X03/doc4.xml…